Notification of Major Interest in Shares

RNS Number : 2634A
Alliance Pharma PLC
18 March 2013
 



For immediate release

18 March 2013

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Major Interest in Shares

 

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was today informed that, on 15 March 2013, Nigel Wray purchased 885,000 ordinary shares of 1p each in the Company.

 

Mr Wray's resultant holding is 36,926,995 ordinary shares, equivalent to 15.07% of the Company's issued share capital.

 

Mr Wray's ordinary shares are held as follows:

 

Nominee

Number of ordinary shares

 

Pershing Nominees Limited

Roy Nominees Limited

 

 

12,262,407

24,664,588

 

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive


Richard Wright, Finance Director


 


Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Oliver Cardigan


Corporate Broking: David Poutney


 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

 

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEALDPFSKDEFF
UK 100

Latest directors dealings